Bio Usawa and Yemaachi Biotech Unite to Transform HealthCare in Africa.
Diasporan biotech innovators co-develop monoclonal antibodies and genomic-driven solutions tailored for African patients. Kigali, Rwanda and Accra, Ghana — In a landmark collaboration, Bio Usawa, a pioneering biotechnology company building Africa’s monoclonal antibody development and manufacturing capacity, and Yemaachi Biotech, a leader in African cancer genomics, have joined forces to accelerate precision medicine and pharmacogenomics […]